A new international study reveals that schizophrenia manifests differently in the brain, reflecting the wide range of symptoms among patients.

Schizophrenia is a severe and debilitating psychiatric disorder that involves psychotic symptoms such as hallucinations and delusions, accompanied with regressive behaviour.

The first line of pharmacological treatment for schizophrenia is antipsychotic medication. However, antipsychotic medications are ineffective in more than 30% of people with the disorder. This is ...

Shares in Neurocrine Bioscience took a tumble after the company reported mid-stage data for a key pipeline drug for schizophrenia ... and Negative Syndrome Scale (PANSS) total score after six ...

The one-dose shot – made by J&J’s Janssen subsidiary – was discussed by the EMA’s Pharmacovigilance Risk Assessment Committee (PRAC) along with AstraZeneca’s jab, which is was subject to ...

Compared to non-interruptive clinical decision support (CDS), interruptive CDS leads to more face-to-face suicide risk assessment ... that well-powered large-scale trials randomizing interruptive ...

A landmark study, involving UCL researchers, has found 69 previously unidentified genetic determinants of rare disease, ...

Undiagnosed mental health sufferers hurt their loved ones along with others by lacking proper treatment particularly when ...

Not all bathroom scales are as accurate as you might expect – especially body fat scales that promise to track more than just your weight. We tested smart, digital and mechanical bathroom scales from ...

Hári Sewell writes about exploring Afro Carribean men's experiences of psychosis and mental health services in North America ...

Rare diseases collectively affect between 4% and 6% of individuals worldwide. Despite advances in genetic testing, the lack ...